⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29824754 | 0.74 | — | — | |
| SCHEMBL2505127 | 0.70 | — | — | |
| SCHEMBL29103257 | 0.68 | — | — | |
| SCHEMBL5089685 | 0.68 | — | — | |
| SCHEMBL2052096 | 0.68 | — | — | |
| SCHEMBL28593767 | 0.65 | — | — | |
| SCHEMBL165813 | 0.65 | — | — | |
| SCHEMBL29257177 | 0.64 | — | — | |
| SCHEMBL987744 | 0.61 | — | — | |
| SCHEMBL4753278 | 0.59 | ALDH1A1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2008514565-A | — | — | 2008-05-08 | — | — | JP | claimed |
| EP-1793822-A1 | TRICYCLES, THEIR MANUFACTURE AND USE AS PHARMACEUTICAL AGENTS | F. Hoffmann-Roche AG (CH) | 2007-06-13 | — | — | EP | claimed |
| WO-2006032519-A1 | TRICYCLES, THEIR MANUFACTURE AND USE AS PHARMACEUTICAL AGENTS | F. HOFFMANN-LA ROCHE AG (CH) | 2006-03-30 | — | — | WO | claimed |
| WO-2003103666-A2 | NOVEL 4,5-DIHYDRO-IMIDAZO[4,5,1-IJ]QUINOLIN-6-ONES | ALTANA PHARMA AG (DE) | 2003-12-18 | — | — | WO | claimed |
| WO-2003104233-A1 | 4,5-DIHYDRO-IMIDAZO (4,5,1-IJ) QUINOLIN-6-ONES DERIVATIVES AND THEIR USE AS POLY (ADP-RIBOSYL) TRANSFERASE (PARP) INHIBITORS | ALTANA PHARMA AG (DE) | 2003-12-18 | — | — | WO | claimed |
| WO-2003020698-A2 | PROTEIN TYROSINE KINASE INHIBITORS | PROCHON BIOTECH LTD. (IL) | 2003-03-13 | — | — | WO | claimed |
| CN-119317623-A | Tricyclic quinolone BCL6 bifunctional degradation agents | 树线生物科学公司 | 2025-01-14 | — | — | CN | disclosed |
| CN-113614082-B | Material for organic electroluminescent device | 默克专利有限公司 | 2024-06-18 | — | — | CN | disclosed |
| EP-3961640-A1 | CONTROL SYSTEM FOR CONTROL OF DISTRIBUTION OF MEDICATION | Zogenix International Limited (GB) | 2022-03-02 | — | — | EP | disclosed |
| EP-3947372-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | Merck Patent GmbH (DE) | 2022-02-09 | — | — | EP | disclosed |
| EP-3829583-A1 | LATE SV40 FACTOR (LSF) INHIBITORS | Trustees of Boston University (US) | 2021-06-09 | — | — | EP | disclosed |
| WO-2020193447-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2020-10-01 | — | — | WO | disclosed |
| WO-2020028757-A1 | LATE SV40 FACTOR (LSF) INHIBITORS | TRUSTEES OF BOSTON UNIVERSITY (US) | 2020-02-06 | — | — | WO | disclosed |
| EP-1274411-A1 | PHENYLETHYLAMINES AND CONDENSED RINGS VARIANTS AS PRODRUGS OF CATECHOLAMINES, AND THEIR USE | Axon Biochemicals B.V. (NL) | 2003-01-15 | — | — | EP | disclosed |
| EP-1003522-A4 | A METHOD FOR PREVENTING OR CONTROLLING CATARACT | UNIV SYDNEY (AU) | 2002-05-02 | — | — | EP | disclosed |
| WO-2001078713-A1 | PHENYLETHYLAMINES AND CONDENSED RINGS VARIANTS AS PRODRUGS OF CATECHOLAMINES, AND THEIR USE | AXON BIOCHEMICALS B.V. (NL) | 2001-10-25 | — | — | WO | disclosed |
| EP-1003522-A1 | A METHOD FOR PREVENTING OR CONTROLLING CATARACT | THE UNIVERSITY OF SYDNEY (AU) | 2000-05-31 | — | — | EP | disclosed |
| WO-1998026784-A1 | A METHOD FOR PREVENTING OR CONTROLLING CATARACT | THE UNIVERSITY OF SYDNEY (AU) | 1998-06-25 | — | — | WO | disclosed |
| US-4954498-A | HYPOTENSIVE AGENTS, ANTICOAGULANTS, CARDIOVASCULAR DISORDERS | BOEHRINGER MANNHEIM GMBH (DE) | 1990-09-04 | — | — | US | disclosed |
| EP-0357172-A2 | Benzofuro[3,2-c]Quinoline compounds | Kissei Pharmaceutical Co., Ltd. (JP) | 1990-03-07 | — | — | EP | disclosed |